ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: HEW Clamps Down On Former Employees Hired To Go After Jobs They Had Helped Develop

May 3, 1974

Center Studies Prevention For Endometrial Cancer

February 25, 2005

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975